Clerimed (clarithromycin) coated tablets 500 mg. №14

Description

Treatment of infections caused by clarithromycin-sensitive microorganisms:
infections of the upper respiratory tract (pharyngitis, tonsillitis), and infection of the paranasal sinuses;
lower respiratory tract infections (bronchitis, acute croup pneumonia, and primary atypical pneumonia) (see “application Features” and “Pharmacological properties. Pharmacodynamics ” on sensitivity testing);
skin and soft tissue infections (impetigo, folliculitis, erysipeloid, furunculosis, infected wounds) (see “application Features” and ” Pharmacological properties. Pharmacodynamics ” on sensitivity testing);
acute and chronic odontogenic infections;
disseminated or localized mycobacterial infections caused by Mycobacterium avium or Mycobacterium intracellulare. Localized infections caused by Mycobacterium chelonae, Mycobacterium fortuitum, or Mycobacterium kansasi;
H. pylori eradication in patients with duodenal ulcer with inhibition of hydrochloric acid secretion (clarithromycin activity against N. pylori at neutral pH is higher than at acidic pH)